Uwe Rix
Researcher
Deparment of Drug Discovery
Moffitt Cancer Center
United States of America
Biography
Dr. Uwe Rix is affiliated to Deparment of Drug Discovery, Moffitt Cancer Center. Dr. Uwe Rix is currently providing services as Researcher. Dr. Uwe Rix has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Uwe Rix contributions have acclaimed recognition from honourable subject experts around the world. Dr. Uwe Rix is actively associated with different societies and academies. Dr. Uwe Rix academic career is decorated with several reputed awards and funding. Dr. Uwe Rix research interests include on chemical biology, targeted drugs, drug-protein interaction networks, synergy and molecular mechanisms of action in the context of cancer research, particularly lung cancer research..
Research Interest
On chemical biology, targeted drugs, drug-protein interaction networks, synergy and molecular mechanisms of action in the context of cancer research, particularly lung cancer research.
Publications
-
Gao B, Huang C, Kernstine K, Pelekanou V, Kluger Y, Jiang T, Peters-Hall JR, Coquelin M, Girard L, Zhang W, Huffman K. Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions. Oncotarget. 2017 Feb 14;8(7):11114.
-
Vaishnavi A, Schubert L, Rix U, Marek LA, Le AT, Keysar S, Glogowska MJ, Smith MA, Kako SL, Sumi NJ, Davies KD. EGFR mediates responses to small molecule drugs targeting oncogenic fusion kinases. Cancer Research. 2017 Jan 1:canres-0109.
-
Wright G, Golubeva V, Remsing Rix LL, Berndt N, Luo Y, Ward GA, Gray JE, Schönbrunn E, Lawrence HR, Monteiro AN, Rix U. Dual targeting of WEE1 and PLK1 by AZD1775 elicits single agent cellular anticancer activity. ACS Chemical Biology. 2017 Jun 7.
